FGF23 is elevated in Gambian children with rickets

Bone

Volumn 42, Issue 4, 2008, Pages 788-797

  Prentice, Ann ^a,b   Ceesay, Mustapha ^a   Nigdikar, Shailja ^b   Allen, Stephen J ^a   Pettifor, John M ^c  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Africa; Calcium deficiency; FGF23; Phosphate; Rickets

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D;

ADOLESCENT; AFRICA; ARTICLE; BONE DEFECT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRESCRIPTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RICKETS; STATISTICAL SIGNIFICANCE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

CHILD; CHILD, PRESCHOOL; FEMALE; FIBROBLAST GROWTH FACTORS; FOLLOW-UP STUDIES; GAMBIA; HUMANS; MALE; RICKETS; TIME FACTORS;

EID: 40849083626     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.11.014     Document Type: Article

References (46)

1. Strewler G.J. Phos, Phex and FGF: mysteries of phosphate homeostasis revealed - or still hidden. BoneKEy-Osteovision 1 (2004) 6-14
2. Silve C., and Beck L. Is FGF23 the long sought after phosphaturic factor phosphatonin?. Nephrol Dial Transplant 17 (2002) 958-961
3. Berndt T., and Kumar R. The phosphatonins and the regulation of phosphorus homeostasis. BoneKEy-Osteovision 2 (2005) 5-16
4. Jonsson K.B., Zahradnik R., Larsson T., White K.E., Sugimoto T., Imanishi Y., et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348 (2003) 1656-1663
5. Riminucci M., Collins M.T., Fedarko N.S., Cherman N., Corsi A., White K.E., et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112 (2003) 683-692
6. Shimada T., Muto T., Urakawa I., Yoneya T., Yamazaki Y., Okawa K., et al. Mutant FGF-23 responsible for autosomal-dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinol 143 (2002) 2179-3182
7. Imel E.A., Hui S.I., and Econs M.J. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res 22 (2007) 520-526
8. Shimada T., Kakitani M., Yamazaki Y., Hasegawa H., Takeuchi Y., Fujita T., et al. Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113 (2004) 561-568
9. 3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 289 (2005) G1036-G1042
10. Weber T.J., Shiguang L., Indridason O.S., and Quarles L.D. Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18 (2003) 1227-1234
11. Yamazaki Y., Okazaki R., Shibata M., Hasegawa Y., Satoh K., Tajima T., et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87 (2002) 4957-4960
12. Pettifor J.M. Nutritional Rickets. In: Glorieux F., Jueppner H., and Pettifor J.M. (Eds). Pediatric bone - biology and diseases (2003), Elsevier Science, San Diego
13. Pfitzner M.A., Thacher T.D., Pettifor J.M., Zoakah A.I., Lawson J.O., Isichei C.O., et al. Absence of vitamin D deficiency in young Nigerian children. J Pediatr 133 (1998) 740-744
14. Oginni L.M., Worsfold M., Oyelami O.A., Sharp C.A., Powell D.E., and Davie M.W.J. Etiology of rickets in Nigerian children. J Pediatr 128 (1996) 692-694
15. Pettifor J.M., Ross P., Wang J., Moodley G., and Cooper-Smith J. Rickets in children of rural origin in South Africa: is low dietary calcium a factor?. J Pediatr 92 (1978) 320-324
16. Fischer P.R., Rahman A., Cimma J.P., Kyaw-Myint T.O., Kabir A.R.M.L., Talukder K., et al. Nutritional rickets without vitamin D deficiency in Bangladesh. J Trop Pediatr 45 (1999) 291-293
17. Prentice A., and Bates C.J. An appraisal of the adequacy of dietary mineral intakes in developing countries for bone growth and development in children. Nutr Res Rev 6 (1993) 51-59
18. Thacher T.D., Fischer P.R., Pettifor J.M., Lawson J.O., Isichei C.O., Reading J.C., et al. A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. N Engl J Med 341 (1999) 563-568
19. Oginni L.M., Sharp C.A., Worsfold M., Badru O.S., and Davie M.W.J. Healing of rickets after calcium supplementation. The Lancet 353 (1999) 296-297
20. Fischer P.R., Thacher T.D., Pettifor J.M., Eccleshall T.R., and Feldman D. Vitamin D receptor polymorphisms and nutritional rickets in Nigerian children. J Bone Miner Res 15 (2000) 2206-2210
21. Prentice A. Calcium nutrition in Gambian women and children. In: Thacher T.D. (Ed). Nutritional rickets in Nigerian children: the way forward. vol. 15 (2002), Nestle Nutrition
22. Freeman J.V., Cole T.J., Chinn S., Jones P.R.M., White E.M., and Preece M.A. Cross-sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 73 (1995) 17-24
23. Thacher T.D., Fischer P.R., Pettifor J.M., Lawson J.O., Manaster B.J., and James C. Radiographic scoring method for the assessment of severity of nutritional rickets. J Trop Pediatr 46 (2000) 132-139
24. Dibba B., Prentice A., Ceesay M., Stirling D.M., Cole T.J., and Poskitt E.M.E. Effect of calcium supplementation on bone mineral accretion in Gambian children accustomed to a low calcium diet. Am J Clin Nutr 71 (2000) 544-549
25. Barth J.H., Fiddy J.B., and Payne R.B. Adjustment of serum total calcium for albumin concentration: effects of non-linearity and of regression differences between laboratories. Ann Clin Biochem 33 (1996) 55-58
26. Arnaud S.B., Stickler G.B., and Haworth J.C. Serum 25-hydroxyvitamin D in infantile rickets. Pediatrics 57 (1976) 221-225
27. Okonofua F., Gill D.S., Alabi Z.O., Thomas M., and Dandona P. Rickets in Nigerian children: a consequence of calcium malnutrition. Metabolism 40 (1991) 209-213
28. Pettifor J.M., Ross F.P., Travers R., Glorieux F.H., and Deluca H.F. Dietary calcium deficiency: a syndrome associated with bone deformities and elevated serum 1,25-dihydroxyvitamin D concentrations. Metab Bone Dis Relat Res 2 (1981) 301-305
29. Shimada T., Hasegawa H., Yamazaki Y., Muto T., Hino R., Takeuchi Y., et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19 (2004) 429-435
30. Ferrari S.L., Bonjour J.P., and Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90 (2005) 1519-1524
31. Larsson T., Nisbeth U., Ljunggren O., Juppner H., and Jonsson K.B. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64 (2003) 2272-2279
32. 3 and phosphorus in vivo. J Biol Chem 280 (2005) 2543-2549
33. Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98 (2001) 6500-6505
34. Ito N., Fukumoto S., Takeuchi Y., Yasuda T., Hasegawa Y., Takemoto F., et al. Comparison of two assays for fibroblast growth factor (FGF)-23. J Bone Miner Metab 23 (2005) 435-440
35. Aspray T.J., Yan L., and Prentice A. Parathyroid hormone and rates of bone formation are raised in perimenopausal rural Gambian women. Bone 36 (2005) 710-720
36. Nordin B.E.C., and Need A.G. The relation between serum calcidiol and calcitriol. BoneKEy-Osteovision 2 (2005) 7-16
37. Clements M.R., Johnson L., and Fraser D.R. A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 324 (1987) 62-65
38. Yoshida T., Fujimori T., and Nabeshima Y.I. Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increase expression of renal 1α-hydroxylase gene. Endocrinol (2006) 143
39. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13 (1998) 325-349
40. Shimada T., Urakawa I., Yanazaki Y., Hasegawa H., Hino R., Yoneya T., et al. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 314 (2004) 409-414
41. 3 production. J Biol Chem 278 (2003) 2206-2211
42. Strewler G.J. The spinner meets the stone: klotho and mineral metabolism. BoneKEy-Osteovision 2 (2005) 29-33
43. Portale A.A., Halloran B.P., Murphy M.M., and Morris Jr. R.C. Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. J Clin Invest 77 (1986) 7-12
44. Portale A.A., Halloran B.P., and Morris R.C. Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest 83 (1989) 1494-1499
45. 2 in children with calcium deficiency rickets. J Pediatr 149 (2006) 840-844
46. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16 (1997) 391-396